참고문헌
- Diamantopoulos A, Katsanos K. Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol 2014;31:345-52. https://doi.org/10.1055/s-0034-1393971
- Kasapis C, Gurm HS. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 2009;5:296-311. https://doi.org/10.2174/157340309789317823
- MacTaggart JN, Phillips NY, Lomneth CS, et al. Three-dimensional bending, torsion and axial compression of the femoropopliteal artery during limb flexion. J Biomech 2014;47:2249-56. https://doi.org/10.1016/j.jbiomech.2014.04.053
- Yin WH. Rotational atherectomy: an update. J Geriatr Cardiol 2013;10:211-2.
- Zeller T, Langhoff R, Rocha-Singh KJ, et al. Directional atherectomy followed by a paclitaxel-coated balloon to inhibit restenosis and maintain vessel patency: twelve-month results of the DEFINITIVE AR study. Circ Cardiovasc Interv 2017;10:e004848.
- DeRubertis BD. Interim results of the REALITY trial. Presented at: VINNOVA Symposium (virtual); 2020 May 16; Beijing, China.
- Dattilo R, Himmelstein SI, Cuff RF. The COMPLIANCE 360° trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol 2014;26:355-60.
- Stavroulakis K, Schwindt A, Torsello G, et al. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for common femoral artery atherosclerotic disease. J Endovasc Ther 2018;25:92-9. https://doi.org/10.1177/1526602817748319
- Kansal A, Long CA, Patel MR, Jones WS. Endovascular treatment of femoro-popliteal lesions. Clin Cardiol 2019;42:175-83. https://doi.org/10.1002/clc.23098
- Cha JJ, Lee JH, Ko YG, et al. Clinical outcomes of atherectomy plus drug-coated balloon versus drug-coated balloon alone in the treatment of femoropopliteal artery disease. Korean Circ J 2022;52:123-33. https://doi.org/10.4070/kcj.2021.0246